Copy to clipboard 
4D Medicine Limited, developer of advanced biomaterials for orthopaedic and surgical applications, is pleased to announce its participation as an exhibitor at the Orthopaedic Manufacturing & Technology Exposition and Conference (OMTEC) 2025, taking place June 18–19 at the Donald E. Stephens Convention Center in Chicago, Illinois.
Attendees are invited to connect with 4D Medicine at Booth #558 where the company will be showcasing 4Degra®, its bioabsorbable polymer platform that offers unprecedented performance in tissue repair and regeneration. This biomaterial, featuring novel polycarbonate urethane chemistry, is designed to meet the evolving needs of the orthopaedic, spine and trauma markets. 4D Medicine will be actively seeking sales channel partners for the Degrafix™ Interference Screw that delivers improved biocompatibility and more predictable resorption to increase surgeon confidence in long-term procedural success. The DegraFix™ interference Screw is the first product in a potential portfolio of improved soft tissue fixation devices.
“We are excited to engage with industry leaders and investors at OMTEC 2025,” said Phil Smith, CEO of 4D Medicine Limited. “Our materials offer unique advantages in terms of processibility, biocompatibility and regenerative potential. We look forward to exploring strategic partnerships that will accelerate commercialization and expand clinical impact.”
Attendees are encouraged to schedule meetings in advance by contacting the 4D Medicine business development team at info@4dmedicine.co.uk.
Source: 4D Medicine
